Abstract |
Laser treatment was used in the past to reduce the visual loss due to diabetic macular edema. The recent advent of anti- vascular endothelial growth factor (anti- VEGF) has completely revolutionized the management of diabetic retinopathy, with a significant improvement in the overall prognosis. Nevertheless, macular laser can still be applied in selected cases characterized by retinal thickness ≤400 microns, high visual acuity, extrafoveal location, and contraindications to the intravitreal approach with anti- VEGF and steroids. In addition, the combined therapy with anti- VEGF and macular laser can exploit the synergistic effects of both therapies, leading to a simpler and more practical management of patients over the long-term follow-up.
|
Authors | Maurizio Battaglia Parodi, Francesco Bandello |
Journal | Developments in ophthalmology
(Dev Ophthalmol)
Vol. 60
Pg. 125-130
( 2017)
ISSN: 1662-2790 [Electronic] Switzerland |
PMID | 28427071
(Publication Type: Journal Article, Review)
|
Copyright | © 2017 S. Karger AG, Basel. |
Topics |
- Decision Making
- Diabetic Retinopathy
(complications, diagnosis, surgery)
- Humans
- Laser Coagulation
(methods)
- Macular Edema
(diagnosis, etiology, surgery)
- Tomography, Optical Coherence
- Visual Acuity
|